- Home
- NVAX vs SFL Comparison
NVAX vs SFL Comparison
Compare NVAX & SFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVAX
- SFL
- Stock Information
- Founded
- NVAX 1987
- SFL 2003
- Country
- NVAX United States
- SFL Bermuda
- Employees
- NVAX N/A
- SFL N/A
- Industry
- NVAX Biotechnology: Biological Products (No Diagnostic Substances)
- SFL Marine Transportation
- Sector
- NVAX Health Care
- SFL Consumer Discretionary
- Exchange
- NVAX Nasdaq
- SFL Nasdaq
- Market Cap
- NVAX 2.0B
- SFL 1.7B
- IPO Year
- NVAX 1995
- SFL N/A
- Fundamental
- Price
- NVAX $8.47
- SFL $11.00
- Analyst Decision
- NVAX Buy
- SFL Strong Buy
- Analyst Count
- NVAX 6
- SFL 1
- Target Price
- NVAX $17.83
- SFL $16.00
- AVG Volume (30 Days)
- NVAX 5.8M
- SFL 952.7K
- Earning Date
- NVAX 11-12-2024
- SFL 11-06-2024
- Dividend Yield
- NVAX N/A
- SFL 9.83%
- EPS Growth
- NVAX N/A
- SFL 39.68
- EPS
- NVAX N/A
- SFL 1.10
- Revenue
- NVAX $885,193,000.00
- SFL $876,068,000.00
- Revenue This Year
- NVAX N/A
- SFL $20.56
- Revenue Next Year
- NVAX N/A
- SFL N/A
- P/E Ratio
- NVAX N/A
- SFL $10.00
- Revenue Growth
- NVAX N/A
- SFL 19.50
- 52 Week Low
- NVAX $3.53
- SFL $10.01
- 52 Week High
- NVAX $23.86
- SFL $14.62
- Technical
- Relative Strength Index (RSI)
- NVAX 41.69
- SFL 57.64
- Support Level
- NVAX $6.81
- SFL $10.01
- Resistance Level
- NVAX $10.39
- SFL $11.18
- Average True Range (ATR)
- NVAX 0.66
- SFL 0.29
- MACD
- NVAX 0.09
- SFL 0.09
- Stochastic Oscillator
- NVAX 46.37
- SFL 84.19
About NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.
About SFL SFL Corporation Ltd
SFL Corp Ltd is an international ship owning and chartering company. The company is engaged primarily in the ownership and operation of vessels and offshore related assets and is also involved in the charter, purchase, and sale of assets. Its oil tankers, chemical tankers, and oil product tankers are all double-hull vessels.